Glaukos Corporation's reaffirmation of its FY23 sales guidance suggests confidence in meeting its revenue targets. Since the guidance is in line with analyst expectations, the short-term impact on the stock price is likely to be neutral. Investors may have already priced in this information, and the announcement does not present new, market-moving data. However, the confirmation may provide some stability to the stock price.